Acquired cutis laxa: Hematological insights and therapeutic implications in a paraneoplastic context
Journal of Clinical and Experimental Hematology · 2024
DOI: 10.46439/hematol.3.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematology, 2024. Verfasst von Joe Khodeir und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acquired cutis laxa (ACL) is an uncommon dermatological condition characterized by loose, inelastic skin due to the degradation of elastic fibers. Traditionally studied within dermatology, recent insights have highlighted significant associations with hematological disorders, particularly monoclonal gammopathies.
Objective
This commentary extends the discussion presented in the review article "Acquired cutis laxa: a clinical review" by Khodeir et al., emphasizing recent advancements in the understanding of ACL’s hematological connections. It focuses on paraneoplastic associations and their treatment, alongside a newly documented case linking ACL with IgA gammopathy.
Methods
A comprehensive review of recent literature and new cumulative data on ACL associated with neoplastic disorders was conducted. A detailed case report illustrates the clinical and pathological findings of ACL associated with IgA lambda paraproteinemia.
Results
Among 110 patients reviewed, 30 cases (27%) were linked to paraneoplastic disorders, primarily multiple myeloma and monoclonal gammopathy of undetermined significance. ACL typically preceded the diagnosis of these conditions by an average of 2.4 years. The newly reported case of ACL with IgA gammopathy further reinforces the link between ACL and monoclonal gammopathies. The pathogenesis involves complex mechanisms including enzymatic degradation of elastic fibers, immunoglobulin-mediated elastolysis, and chronic inflammation.
Conclusion
ACL presents a dermatological challenge increasingly linked to hematological disorders, particularly monoclonal gammopathies. Recognizing ACL as a potential paraneoplastic marker underscores the need for thorough hematological evaluation and long-term follow-up in patients. Continued research into the pathogenesis and therapeutic strategies is crucial for improving clinical outcomes and refining management guidelines for ACL.
Zitieren
APA
Khodeir, J., Ohanian, P., & Zhou, Z. (2024). Acquired cutis laxa: Hematological insights and therapeutic implications in a paraneoplastic context. Journal of Clinical and Experimental Hematology. https://doi.org/10.46439/hematol.3.018
Vancouver
Khodeir J, Ohanian P, Zhou Z. Acquired cutis laxa: Hematological insights and therapeutic implications in a paraneoplastic context. Journal of Clinical and Experimental Hematology. 2024. doi:10.46439/hematol.3.018
BibTeX
@article{Khodeir2024,
author = {Khodeir, Joe and Ohanian, Paul and Zhou, Zhongren},
title = {Acquired cutis laxa: Hematological insights and therapeutic implications in a paraneoplastic context},
journal = {Journal of Clinical and Experimental Hematology},
year = {2024},
doi = {10.46439/hematol.3.018}
}
EUVIMED